スポンサーリンク
The Third Department of Internal Medicine University of Tokyo | 論文
- -270- EXPERIMENTAL EVALUATION OF STUNNED MYOCARDIUM BY TWO DIMENTIONAL ECHOCARDIOGRAPHY AND MYOSIN LIGHT CHAIN II LEVELS : Ischemic Heart Diseases : FREE COMMUNICATIONS(II) : PROCEEDINGS OF THE 51th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SO
- -P99- DETECTION OF SUBENDOCARDIAL OR RIGHT VENTRICULAR INFARCTION WITH LABELED ANTIMYOSIN HEAVY CHAIN MONOCLONAL ANTIBODY : RI : FREE COMMUNICATIONS(I) : PROCEEDINGS OF THE 51th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY
- INTRACELLULAR ASSEMBLING OF NEWLY SYNTHESIZED CARDIAC MUSCLE MYOSINS : ANALYSIS BY IMMUNOELECTRON MICROSCOPY WITH ENZYME LABELED MONOCLONAL ANTIBODY : Myocardial Biochemistry : PROCEEDINGS OF THE 50th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION
- -34-AN IMMUNORADIOMETRIC ASSAY OF SERUM CARDIAC MYOSIN LIGHT CHAIN I : A NEW METHOD OF MYOCARDIAL INFARCT SIZING
- EFFECTS OF CORONARY REPERFUSION ON INFARCT SIZE, RELEASE OF CREATINE KINASE AND CARDIAC MYOSIN LIGHT CHAIN IN CLOSE-CHEST CONSCIOUS DOOS : Ischemic Heart Disease (II) : FREE COMMUNICATIONS (II) : PROCEEDINGS OF THE 49th ANNUAL SCIENTIFIC MEETING OF THE JA
- A NEW METHOD OF IMAGES OF MYOCARDIAL INFARCTION WITH LABELLED MONOCLONAL ANTIBODY SPECIFIC FOR VENTRICULAR MYOSIN HEAVY CHAIN : Nuclear Cardiology (I) : FREE COMMUNICATIONS (I) : PROCEEDINGS OF THE 49th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATIO
- Applications of Anticardiac Myosin Monoclonal Antibodies in the Diagnosis of Heart Disease : PANEL DISCUSSION ON PROGRESS IN NONINVASIVE CARDIAC DIAGNOSIS
- OJ-061 Association analysis between autosomal recessive hypercholesterolemia (ARH) gene and hypercholesterolemia(Lipid Disorders 1 (H) : OJ8)(Oral Presentation (Japanese))
- 3 Endothelial-cardiomyocyte Interactions Play Important Roles in Erythropoietin-induced Cardioprotective Effects after Myocardial Infarction(Interaction between Myocardium and Vasculature in Heart Failure-Novel Insights from Cytokine Signal Network-,Sympo
- PJ-378 Decreased Circulating CD34-positive Cells are Associated with High Plasma BNP Concentration in Elderly Patients with Type 2 Diabetes Mellitus(Diabetes/Obesity/Metabolic syndrome-9 (H) PJ64,Poster Session (Japanese),The 70th Anniversary Annual Scien
- Obesity and Insulin Resistance Possibly Promotes Ischemic Heart Disease of the Patients with Familial Combined Hyperlipidemia (FCHL)(Lipid Disorders 4 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- OJ-327 Fluvastatin Increases Transcriptional Activity of the Endothelial Nitric Oxide Synthase Gene, Especially With -786T/C Polymorphism(Cardiovascular Pharmacology, Basic/Clinical 2 (H) : OJ39)(Oral Presentation (Japanese))
- Differential Gene Expression in Myocardial Infarction in Diabetic Obese Mice
- FRS-102 Event rates of Japanese patients with atherothrombosis : Results from the REduction of Atherothrombosis for Continued Health (REACH) Registry(Clinical Frontiers in Atherosclerosis(IHD),Featured Research Session,The 72nd Annual Scientific Meeting o
- Difference between Fluvastatin and Simvastatin on the eNOS Gene Expression (Cardiovascular Pharmacology, Basic/Clinical 2 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- 1 Beyond lowering blood pressure effect of nifedipine retard : Nifedipine retard prevents hospitalization for angina pectoris better than angiotensin-converting enzyme inhibitors in hypertensive Japanese patients with a history of myocardial infarction (J
- Signal Transduction Mechanism of Insulin and Insulin-Like Growth Factor-1
- Unstable Angina and Non-ST Elevation Acute Coronary Syndrome : Epidemiology and Current Management in Japan (Japan Multicenter Investigation for Cardiovascular Disease-D (JMIC-D) Committee)
- PJ-120 Nifedipine Retard and ACE Inhibitors Did Not Show the Similar Relationship between Cardiac Events and Achieved Systolic Blood Pressure(Hypertension, Clinical 2 (H) : PJ20)(Poster Session (Japanese))
- OJ-249 Long-term Efficacy of Nifedipine Retard and ACE Inhibitors in Diabetic Patients with Hypertension and Coronary Artery Disease : JMIC-B Subgroup analysis(Hypertension, Clinical 5 (H) : OJ29)(Oral Presentation (Japanese))
スポンサーリンク